Document
IPR2023-00049, No. 1 Petition as filed - Petition as filed (P.T.A.B. Oct. 14, 2022)
Cite Document
IPR2023-00049, No. 1 Petition as filed - Petition as filed (P.T.A.B. Oct. 14, 2022)
+ More Snippets
Document
IPR2023-00049, No. 2 Notice Power of Attorney - Notice Power of Attorney (P.T.A.B. Oct. 14, 2022)
Cite Document
IPR2023-00049, No. 2 Notice Power of Attorney - Notice Power of Attorney (P.T.A.B. Oct. 14, 2022)
+ More Snippets
Document
CLADRIBINE REGIMEN FOR TREATING MULTIPLE SCLEROSIS, 11/722,018, No. LWB3XR2SGREENX2 (U.S. Pat. App. May. 17, 2024)
Cite Document
CLADRIBINE REGIMEN FOR TREATING MULTIPLE SCLEROSIS, 11/722,018, No. LWB3XR2SGREENX2 (U.S. Pat. App. May. 17, 2024)
+ More Snippets
Document
CLADRIBINE REGIMEN FOR TREATING MULTIPLE SCLEROSIS, 11/722,018, No. LQCI3ZLSGREENX2 (U.S. Pat. App. Dec. 19, 2023)
Cite Document
CLADRIBINE REGIMEN FOR TREATING MULTIPLE SCLEROSIS, 11/722,018, No. LQCI3ZLSGREENX2 (U.S. Pat. App. Dec. 19, 2023)
+ More Snippets
Document
CLADRIBINE REGIMEN FOR TREATING MULTIPLE SCLEROSIS, 11/722,018, No. LMUV16NWXBLUEX5 (U.S. Pat. App. Sep. 22, 2023)
Cite Document
CLADRIBINE REGIMEN FOR TREATING MULTIPLE SCLEROSIS, 11/722,018, No. LMUV16NWXBLUEX5 (U.S. Pat. App. Sep. 22, 2023)
+ More Snippets
Document
CLADRIBINE REGIMEN FOR TREATING MULTIPLE SCLEROSIS, 11/722,018, No. LMUMQ781XBLUEX4 (U.S. Pat. App. Sep. 22, 2023)
Cite Document
CLADRIBINE REGIMEN FOR TREATING MULTIPLE SCLEROSIS, 11/722,018, No. LMUMQ781XBLUEX4 (U.S. Pat. App. Sep. 22, 2023)
+ More Snippets
Document
CLADRIBINE REGIMEN FOR TREATING MULTIPLE SCLEROSIS, 11/722,018, No. LB45YLAIXBLUEX0 (U.S. Pat. App. Nov. 30, 2022)
Cite Document
CLADRIBINE REGIMEN FOR TREATING MULTIPLE SCLEROSIS, 11/722,018, No. LB45YLAIXBLUEX0 (U.S. Pat. App. Nov. 30, 2022)
+ More Snippets
Document
CLADRIBINE REGIMEN FOR TREATING MULTIPLE SCLEROSIS, 11/722,018, No. LB45VY08XBLUEX4 (U.S. Pat. App. Nov. 30, 2022)
Cite Document
CLADRIBINE REGIMEN FOR TREATING MULTIPLE SCLEROSIS, 11/722,018, No. LB45VY08XBLUEX4 (U.S. Pat. App. Nov. 30, 2022)
+ More Snippets
Document
CLADRIBINE REGIMEN FOR TREATING MULTIPLE SCLEROSIS, 11/722,018, No. L6C7W55AXBLUEX5 (U.S. Pat. App. Aug. 2, 2022)
Cite Document
CLADRIBINE REGIMEN FOR TREATING MULTIPLE SCLEROSIS, 11/722,018, No. L6C7W55AXBLUEX5 (U.S. Pat. App. Aug. 2, 2022)
+ More Snippets
Document
CLADRIBINE REGIMEN FOR TREATING MULTIPLE SCLEROSIS, 11/722,018, No. LFSCG5J0XBLUEX3 (U.S. Pat. App. Mar. 28, 2023)
Cite Document
CLADRIBINE REGIMEN FOR TREATING MULTIPLE SCLEROSIS, 11/722,018, No. LFSCG5J0XBLUEX3 (U.S. Pat. App. Mar. 28, 2023)
+ More Snippets
Document
CLADRIBINE REGIMEN FOR TREATING MULTIPLE SCLEROSIS, 11/722,018, No. LFRCMYBUXBLUEX3 (U.S. Pat. App. Mar. 27, 2023)
Cite Document
CLADRIBINE REGIMEN FOR TREATING MULTIPLE SCLEROSIS, 11/722,018, No. LFRCMYBUXBLUEX3 (U.S. Pat. App. Mar. 27, 2023)
+ More Snippets
Document
CLADRIBINE REGIMEN FOR TREATING MULTIPLE SCLEROSIS, 11/722,018, No. LFRCMYBTXBLUEX3 (U.S. Pat. App. Mar. 27, 2023)
Cite Document
CLADRIBINE REGIMEN FOR TREATING MULTIPLE SCLEROSIS, 11/722,018, No. LFRCMYBTXBLUEX3 (U.S. Pat. App. Mar. 27, 2023)
+ More Snippets
Document
CLADRIBINE REGIMEN FOR TREATING MULTIPLE SCLEROSIS, 11/722,018, No. LFRCMYBVXBLUEX3 (U.S. Pat. App. Mar. 27, 2023)
Cite Document
CLADRIBINE REGIMEN FOR TREATING MULTIPLE SCLEROSIS, 11/722,018, No. LFRCMYBVXBLUEX3 (U.S. Pat. App. Mar. 27, 2023)
+ More Snippets
Document
CLADRIBINE REGIMEN FOR TREATING MULTIPLE SCLEROSIS, 11/722,018, No. KXAEW9DZLDFLYX9 (U.S. Pat. App. Dec. 17, 2021)
Cite Document
CLADRIBINE REGIMEN FOR TREATING MULTIPLE SCLEROSIS, 11/722,018, No. KXAEW9DZLDFLYX9 (U.S. Pat. App. Dec. 17, 2021)
+ More Snippets
Document
CLADRIBINE REGIMEN FOR TREATING MULTIPLE SCLEROSIS, 11/722,018, No. KXAEW9DTLDFLYX9 (U.S. Pat. App. Dec. 17, 2021)
Cite Document
CLADRIBINE REGIMEN FOR TREATING MULTIPLE SCLEROSIS, 11/722,018, No. KXAEW9DTLDFLYX9 (U.S. Pat. App. Dec. 17, 2021)
+ More Snippets